Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Front Immunol. 2022 Apr 7;13:865888. doi: 10.3389/fimmu.2022.865888. eCollection 2022.
Various factors, including viral and bacterial infections, autoimmune responses, diabetes, drugs, alcohol abuse, and fat deposition, can damage liver tissue and impair its function. These factors affect the liver tissue and lead to acute and chronic liver damage, and if left untreated, can eventually lead to cirrhosis, fibrosis, and liver carcinoma. The main treatment for these disorders is liver transplantation. Still, given the few tissue donors, problems with tissue rejection, immunosuppression caused by medications taken while receiving tissue, and the high cost of transplantation, liver transplantation have been limited. Therefore, finding alternative treatments that do not have the mentioned problems is significant. Cell therapy is one of the treatments that has received a lot of attention today. Hepatocytes and mesenchymal stromal/stem cells (MSCs) are used in many patients to treat liver-related diseases. In the meantime, the use of mesenchymal stem cells has been studied more than other cells due to their favourable characteristics and has reduced the need for liver transplantation. These cells increase the regeneration and repair of liver tissue through various mechanisms, including migration to the site of liver injury, differentiation into liver cells, production of extracellular vesicles (EVs), secretion of various growth factors, and regulation of the immune system. Notably, cell therapy is not entirely excellent and has problems such as cell rejection, undesirable differentiation, accumulation in unwanted locations, and potential tumorigenesis. Therefore, the application of MSCs derived EVs, including exosomes, can help treat liver disease and prevent its progression. Exosomes can prevent apoptosis and induce proliferation by transferring different cargos to the target cell. In addition, these vesicles have been shown to transport hepatocyte growth factor (HGF) and can promote the hepatocytes'(one of the most important cells in the liver parenchyma) growths.
多种因素,包括病毒和细菌感染、自身免疫反应、糖尿病、药物、酗酒和脂肪沉积,都可能损害肝脏组织并损害其功能。这些因素会影响肝脏组织,导致急性和慢性肝损伤,如果不加以治疗,最终可能导致肝硬化、纤维化和肝癌。这些疾病的主要治疗方法是肝移植。然而,由于组织供体数量较少、组织排斥问题、接受组织时服用的药物引起的免疫抑制以及移植的高昂成本,肝移植受到了限制。因此,寻找没有上述问题的替代治疗方法非常重要。细胞疗法是当今受到广泛关注的治疗方法之一。肝细胞和间充质基质/干细胞(MSCs)已被用于许多患者治疗肝脏相关疾病。同时,由于其有利的特性,间充质干细胞的使用比其他细胞研究得更多,并减少了肝移植的需求。这些细胞通过多种机制促进肝脏组织的再生和修复,包括迁移到肝损伤部位、分化为肝细胞、产生细胞外囊泡(EVs)、分泌各种生长因子以及调节免疫系统。值得注意的是,细胞疗法并非完全完美,存在细胞排斥、不理想的分化、在不需要的位置积累以及潜在的致瘤性等问题。因此,应用间充质干细胞衍生的 EVs,包括外泌体,可以帮助治疗肝脏疾病并防止其进展。外泌体可以通过将不同的货物转移到靶细胞来防止细胞凋亡并诱导增殖。此外,这些囊泡已被证明可以运输肝细胞生长因子(HGF)并促进肝细胞(肝脏实质中最重要的细胞之一)的生长。